You are here

Home » News

Health Services

Approved: Saliva-cased COVID-19 test

FDA approves Yale's new saliva-based COVID-19 test
Posted by Fred Steiner on September 5, 2020 - 6:43am

This column is provided by the ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a saliva test for SARS-CoV-2, the virus that causes COVID-19 infection.

This approval was granted to the Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test.

Section: 
Health Services
»

Kidney stone prevention

Everything you need to know about kidney stones
Posted by Anne Pannabecke... on August 29, 2020 - 6:00am

This column is provided by ONU HealthWise Pharmacy.

Kidney stones may be small, but they can pack a lot of pain. Read on to find out how you can reduce your chance of developing kidney stones.

Kidney stones form in the kidneys and can cause discomfort and pain. They can be small, but large ones can become stuck in the urinary tract, blocking the flow of urine and causing intense pain.

Section: 
Health Services
»

Multi-condition nasal spray recalled

Manufacturers of desmopressin nasal spray recalls all lots
Posted by Anne Pannabecke... on August 22, 2020 - 6:00am

This column is provided by Ohio Northern University HealthWise Pharmacy.

All lots of Ferring Pharmaceuticals' multi-condition nasal spray are being recalled.

The problem? These lots have higher-than-specified amounts of desmopressin.

Higher amounts of desmopressin can lead to abnormally low levels of sodium in the blood. And very low levels of sodium in the blood can lead to dangerous health events, such as seizures, coma and even death.

Section: 
Health Services
»

Nasal spray for depression gets new approved use

FDA approves Spravato (esketamine) to treat major depressive disorder
Posted by Fred Steiner on August 15, 2020 - 6:00am

This column provided by ONU HealthWise Pharmacy.
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.

Approved for treatment-resistant depression (TRD) in March of 2019, esketamine is now approved to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior.

Section: 
Health Services
»

New COVID-19 test gets green light

FDA approves first COVID-19 test for those without symptoms
Posted by Fred Steiner on August 8, 2020 - 6:57am

This column is provided by the ONU HealthWise Pharmacy.
The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a new COVID-19 diagnostic test that can test people who are not showing symptoms.

This test is found under the name LabCorp COVID-19 RT-PCR.

This test was originally given an EUA in early March. It was to test those whose health care providers suspected that they might have COVID-19, and it only tested individual specimens (no sample pooling). But that changed with this new EUA from the FDA.

Section: 
Health Services
»

COVID-19 and flu test combined

FDA approves test that can detect both COVID-19 and flu
Posted by Fred Steiner on August 1, 2020 - 6:21am

This column is provided by ONU HeathWise Pharmacy.
 The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a third combination test for COVID-19 and the flu.

This new test is found under the name Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.

The FDA previously issued EUAs to BioFire Diagnostics LLC and QIAGEN GmbH for their combination tests. These particular combination tests can help identify other respiratory organisms in addition to the viruses that cause the flu and COVID-19.

Section: 
Health Services
»

Pages